- Home
- AIRS vs AGD Comparison
AIRS vs AGD Comparison
Compare AIRS & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIRS | AGD |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.3M | 288.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AIRS | AGD |
|---|---|---|
| Price | $2.15 | $12.27 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.75 | N/A |
| AVG Volume (30 Days) | ★ 603.5K | 61.2K |
| Earning Date | 11-07-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $157,554,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.53 | $8.20 |
| 52 Week High | $12.00 | $9.78 |
Technical Indicators
Market Signals| Indicator | AIRS | AGD |
|---|---|---|
| Relative Strength Index (RSI) | 32.44 | 62.53 |
| Support Level | $1.83 | $11.45 |
| Resistance Level | $2.24 | $12.30 |
| Average True Range (ATR) | 0.18 | 0.23 |
| MACD | 0.15 | 0.03 |
| Stochastic Oscillator | 43.87 | 87.47 |
Price Performance
Historical ComparisonAbout AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.